ScienceAlert46m
First New Schizophrenia Treatment in Decades a Much-Needed Alternative
Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...
FDA Approves groundbreaking drug for schizophrenia treatment
On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.
Strategic Focus and BMY Collaboration Bolster Prime Medicine’s Financial Outlook: Hold Rating Affirmed
Morgan Stanley analyst Terence Flynn has maintained their neutral stance on PRME stock, giving a Hold rating today. Terence Flynn’s ...
Buy Rating Reaffirmed for Prime Medicine on Strong Cash Position and Promising Technology Platforms
Prime Medicine, Inc. (PRME – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...